Meanwhile, MARCH1 expression was significantly decreased in colon adenocarcinoma (COAD), LUAD, lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PAAD), and rectum adenocarcinoma (READ) (Figure 6A). This evidence concerns the gene MARCHF1 and prostate adenocarcinoma.